Jane Street’s Jaguar Health JAGX Stock Holding History

Jane Street’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Hold	0	–	-$23K	–	10097
2021 Q1	–	Hold	0	–	–	–	8959

Other funds holding JAGX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jane Street's JAGX Position: Q2 2024 in Review

Jane Street sold out of Jaguar Health (JAGX) in Q2 2024, closing a stake of 17 shares — an estimated $71.8K sold.

Jane Street first reported a position in JAGX in Q1 2024 and held it in 1 quarter. The position peaked at $71.8K in Q1 2024. 6 funds tracked by Wall St. Rank hold JAGX as of Q2 2024.

Jane Street reported no remaining Jaguar Health position as of Q2 2024 after selling out during the quarter.
Jane Street sold 17 Jaguar Health shares in Q2 2024, an estimated $71.8K.
Jane Street first reported a position in Jaguar Health in Q1 2024 and held it in 1 quarter.
Jane Street's Jaguar Health position peaked at $71.8K in Q1 2024.
6 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.